A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer

A Phase 1b/2, Open-Label, Multicohort Study of Disitamab Vedotin in Adults with HER2 Expressing Advanced Breast Cancer

Disease Types: Breast

Available at: Alleghany, Blacksburg, Roanoke, Salem, Wytheville

A Phase 1b/2, Open-Label, Multicohort Study of Disitamab Vedotin in Adults with HER2 Expressing Advanced Breast Cancer

For More Information:

https://clinicaltrials.gov/study/NCT06966453?term=Disitamab%20Vedotin%20in%20Adults%20with%20HER2%20Expressing%20Advanced%20Breast%20Cancer&rank=1